SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is trending amid community excitement around a potential short squeeze, with traders actively discussing high short interest and a low float. The stock's price action and volume are fueling speculation about a significant upward move, with some comparing it to past high-flying stocks. Community members are also sharing information related to the company's new integrated energy strategy.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following strong earnings, with the community weighing in on the implications for the broader market and AI sector. Bullish sentiment is fueled by raised price targets and confidence in future growth, while some traders express concern about valuation and potential market corrections. Discussions also include the impact of economic data and geopolitical factors on NVIDIA's outlook.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending due to rising memory chip prices driven by AI data center demand, with some analysts predicting substantial future growth and a new price target. Community discussions reflect bullish sentiment, but also caution about potential pullbacks after a significant year-to-date increase. Some traders point to technical indicators suggesting it may be overbought in the short-term.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending as investors assess the potential impacts of a government shutdown and subsequent SNAP benefit disruptions on the retailer's sales, with community members closely monitoring key support levels. Bullish sentiment remains due to the stock's defensive nature and potential AI integrations, while others express concerns about valuation and upcoming earnings. Additionally, discussion includes Walmart's move to sell rare sneakers and partnerships with Eli Lilly for drug distribution.

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Farmington, UT.

PACS Group Inc.

PACS Group is trending following a notable pre-market surge and the release of upbeat full-year guidance, sparking considerable community discussion around potential short squeezes and analyst price targets. The stock's movement is also being discussed in the context of a possible rotation into small caps after strong performance from large-cap stocks. Community members are actively debating fair value estimates, the impact of past compliance issues, and the potential for PACS to trade at multiples comparable to its peers.

Klarna Group Plc operates as an investment holding company. It provides an e-commerce payment solutions for merchants and shoppers. The firm connect an array of different financial services and commerce organizations, from PSPs, traditional banks, card networks and open banking providers, to commerce enablers, technology partners, in-store payments providers and shipping and return logistics providers. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Bitmine Immersion Technologies, Inc. is a blockchain technology company, which engages in industrial scale digital asset mining, equipment sales, and hosting operations. It operates through the Cryptocurrency Mining Industry segment. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

MCRB is trending as chatter revolves around potential acquisition, particularly by Nestle, with some suggesting a deal may be imminent due to recent company actions and insider activity. The community is actively debating the likelihood and timing of a buyout versus a partnership, with many expressing frustration over the prolonged wait and the company's silence on the matter. Discussions also include potential price targets and the impact of a deal on shareholders, amid mixed opinions on the company's management and future prospects.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks ($PANW) is trending amid discussions around its recent earnings, where strong results were overshadowed by investor concerns about the acquisition of Chronosphere. Community chatter revolves around analyst upgrades and price target adjustments, with some traders eyeing a potential breakout while others express skepticism about the stock's valuation and near-term direction in the cybersecurity sector.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending amid discussions about potential U.S. government backing and permitting progress for deep-sea mining, spurred by recent comments from political figures and analyst ratings. Community members are weighing the potential for short squeezes and long-term growth in the critical minerals sector. Recent price action and high call option volume are fueling speculation about a potential rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The outcome was unsurprising as Novo Nordisk Foundation controls 77% of the votes at the Novo Nordisk Annual General Meeting.</li><li>Sorensen said he intends to stay on in the role for a maximum of three years.</li></ul>Novo Nordisk (NVO) said on Friday that Lars Rebien Sørensen, the chair of its dominant shareholder, Novo Nordisk Foundation, has been elected as chair of the Board at the drugmaker, replacing Helge Lund.The outcome was unsurprising as Novo Nordisk Foundation controls 77% of votes at the Novo Nordisk Annual General Meeting through its investment company, Novo Holdings A/S. Sørensen was also previously the CEO of Novo from 2000 to 2016. &nbsp;<h2 class="st-heading-2">The New Chairman</h2>Sørensen, however, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916459">said</a> that he intends to hold the position only for a period of two to three years. “My mandate is very clear. I have two important tasks together with the Board: First, to support the CEO and the management in its transformation plans to regain its competitive leadership, and second, prepare the way for my successor,” he said.Novo named Mike Doustdar as CEO of the company in August after Lars Fruergaard Jørgensen stepped down in May. Jørgensen decided to step down as per a mutual agreement with the Novo Nordisk board. The board stated that the change is being made in light of Novo Nordisk's recent market challenges, the company’s declining share price since mid-2024, and discussions with the Novo Nordisk Foundation.Sorensen on Friday also said that he is looking to “strengthen the board with some qualifications,” with recent pharma or over-the-counter business experience. “We might see a future where our GLP-1 product is going in this direction,” he said, highlighting the company’s ambitions to make its drugs over-the-counter without prescription.Minority shareholders, including Norway’s sovereign wealth fund and CalSTRS, opposed Sorensen’s appointment. Proxy advisor ISS also urged investors to abstain, citing “limited transparency and accountability to minority shareholders.”<h2 class="st-heading-2">Other appointments</h2>Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday.The new appointment comes amid Novo’s intense competition in the weight-loss drug market with its U.S. counterpart, Eli Lilly, and a dramatic board rupture last month, in which disagreements over governance principles between Novo’s board and the foundation prompted more than half of the supervisory board to resign.<a href="https://stocktwits.com/symbol/NVO">Shares of NVO</a> traded 2% lower by Thursday noon. On Stocktwits, retail sentiment around NVO rose from ‘bearish’ to ‘neutral’ territory over the past 24 hours while message volume jumped from ‘normal’ to ‘high’ levels.A Stocktwits user expressed optimism about the stock, citing the price-to-earnings valuation.<stembedurl>https://stocktwits.com/Bassfisher89/message/636229521</stembedurl>Another expressed hopes for the stock’s prospects.<stembedurl>https://stocktwits.com/Natetruu/message/636213210</stembedurl>NVO shares are down by 44% this year and by 54% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/scholar-rock-eyes-reapplication-for-approval-of-muscle-atrophy-therapy-in-2026/cLPQ17HRE4q">Why Did Scholar Rock Soar 26% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. 

Novo Nordisk Brings Back Former CEO To Lead Board

Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday. 

Equity

Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday. 


<ul class="summary-bullets"><li>The new plant opened in North Carolina is Toyota’s eleventh in the U.S. and its only battery plant outside Japan.&nbsp;</li><li>The batteries made at the plant will power vehicles including the Camry HEV, Corolla Cross HEV, RAV4 HEV, and a yet-to-be-announced all-electric 3-row BEV.</li><li>The additional $10 billion investment will bring Toyota’s total investment in the U.S. to nearly $60 billion since the carmaker started operations in the country.</li></ul>Japanese automaker Toyota Motor (TM) announced on Wednesday that it will invest up to an additional $10 billion in the U.S. over the next five years, as it seeks to expand its operations in its key market.The additional investment will bring Toyota’s total investment in the U.S. to nearly $60 billion since the carmaker started operations in the country.<h2 class="st-heading-2">New Plant Kick Start</h2>The company on Wednesday also kick-started production at its all-new $14 billion battery plant in Liberty, North Carolina. The plant is Toyota’s eleventh in the U.S. and its only battery plant outside Japan.The 1,850-acre site is expected to create up to 5,100 new jobs and produce 30 GWh annually at full capacity, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://global.toyota/en/newsroom/corporate/43553969.html">stated.</a> It will serve as the development and production hub for lithium-ion batteries needed for Toyota’s electrified vehicles, with 14 battery production lines supporting hybrid electric vehicles (HEVs), battery electric vehicles (BEVs), and plug-in hybrid electric vehicles (PHEVs).The batteries made at the plant will power vehicles including the Camry HEV, Corolla Cross HEV, RAV4 HEV, and a yet-to-be-announced all-electric 3-row BEV. It currently ships HEV modules to both Toyota Kentucky and Mazda Toyota Manufacturing in Alabama, the company said.<h2 class="st-heading-2">Trump’s Push</h2>The investment announcement comes as President Trump is pushing for more investments in the country, including through the imposition of high tariffs on imported vehicles.“Go out and buy a Toyota,” Trump said last month in an address to U.S. troops aboard the USS George Washington at the Yokosuka Naval Base after the Japanese PM informed him that Toyota is planning a $10 billion investment.According to Toyota estimates, the company has sold more than 6.6 million hybrid, plug-in hybrid, fuel cell, and battery electric vehicles in the U.S. since 2000.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/TM">TM stock</a> jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.TM stock is up by 6% this year and by 18% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/uber-coo-says-robotaxi-tech-is-largely-ready-but-hardware-costs-are-still-too-high/cLPICXdREd7">Uber COO Says Robotaxi Tech Is Largely Ready But Hardware Costs Are Still Too High</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Raindrops are seen on Toyota car logo in Krakow, Poland on December 23, 2024. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Toyota Commits Up To $10B Additional Investments In US Over Five Years

The company also kick-started production at its all-new $14 billion battery plant in Liberty, North Carolina, on Wednesday.

<ul class="summary-bullets"><li>The facility is part of the company’s commitment, earlier this year, to invest $23 billion in the U.S. over the next five years.&nbsp;</li><li>Novartis is now also planning two additional RLT manufacturing facilities in Florida and Texas.&nbsp;</li><li>The U.S. is one of Novartis’ priority geographies in addition to China, Germany, and Japan.</li></ul>Novartis (NVS) on Monday said that it has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California, marking its third RLT manufacturing site in the country.The facility is part of the company’s commitment earlier this year to invest $23 billion in the U.S. over the next five years.<h2 class="st-heading-2">Goals Of The New Facility</h2>The new facility is designed to add capacity for radioligand therapy, meeting future demand, and enhance the company’s supply chain capabilities, Novartis <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.novartis.com/news/media-releases/novartis-opens-new-radioligand-therapy-manufacturing-facility-california-part-23b-us-expansion-plan">stated.</a>Radioligand therapy is a targeted cancer treatment that combines a radioactive substance (radioisotope) with a cancer-targeting molecule (ligand). It is aimed at reducing damage to surrounding cells.However, each RLT dose is custom-made and time-sensitive, making proximity to treatment centers and transit hubs necessary for patient access. The new site will ensure access to patients across the western U.S., Alaska, and Hawaii, Novartis said.Commercial manufacturing at the facility is expected to begin once approval is granted by the U.S. Food and Drug Administration, the company added.<h2 class="st-heading-2">Future Expansion Plans</h2>Novartis is now also planning two additional RLT manufacturing facilities in Florida and Texas. &nbsp;In addition, it is also eyeing expansion of existing sites in Durham, North Carolina, Indianapolis, Indiana, and Millburn, New Jersey, and expects to establish a second global research and development hub in the U.S. in San Diego, California.The U.S. is one of Novartis’ priority geographies, alongside China, Germany, and Japan.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/NVS">NVS stock</a> stayed within the ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.NVS stock is up 31% this year and approximately 20% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/grab-holdings-to-take-equity-interest-in-remote-driving-tech-startup/cLPcKrSRE2c">Grab Deepens Autonomous Mobility Push With $60 Million Investment In Vay</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Novartis company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence

Commercial manufacturing at the facility is expected to begin once approval is granted by the U.S. Food and Drug Administration, the company added.

<ul class="summary-bullets"><li>The NHTSA stated that the vehicles in the recall may have been built with a high-voltage battery pack manufactured using cells that are susceptible to separator damage.&nbsp;</li><li>The company stated that a review of customer data led to an internal investigation, which uncovered 19 fires.</li><li>Stellantis warned vehicle owners to refrain from recharging their vehicles until a remedy is ready.&nbsp; &nbsp;</li></ul>Stellantis NV (STLA) is recalling 320,065 Jeep vehicles in the U.S. over fire risks, the National Highway Traffic Safety Administration (NHTSA) said on Tuesday.The recall includes certain model year 2020- 2025 Jeep Wrangler 4Xe and model year 2022-2026 Grand Cherokee 4Xe plug-in hybrid vehicles.<h2 class="st-heading-2">What Causes The Fire?</h2>The vehicles in the recall may have been built with a high-voltage battery pack manufactured using cells that are susceptible to separator damage, the regulator <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://static.nhtsa.gov/odi/rcl/2025/RCLRPT-25V741-6856.pdf">noted</a>.Separator damage combined with other interactions within the cells may lead to a vehicle fire when parked or driving, increasing the risk of injury to persons inside and outside the vehicle.<h2 class="st-heading-2">Company Guidelines And Remedy</h2>The chances of a fire are reduced when the battery charge level is depleted, and the automaker thereby <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://media.stellantisnorthamerica.com/newsrelease.do?id=27207&amp;mid=1">advised</a> owners to refrain from recharging. It also advised that the vehicles be parked away from structures or other vehicles until the remedy is obtained. The remedy, meanwhile, is under development.The company also stated that a review of customer data led to an internal investigation, which uncovered 19 fires. The company estimates that about 20,753 vehicles are affected by the issue in Canada, 2,653 in Mexico, and 32,238 in certain markets outside North America.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2><a href="https://stocktwits.com/symbol/STLA">STLA shares</a> traded 3% lower at the time of writing. On Stocktwits, retail sentiment around STLA fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:624/60;" src="data:image/png;base64,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" width="624" height="60" alt="STLA's Sentiment Meter and Message Volume as of 12:43 p.m. ET on Nov. 4, 2025 | Source: Stocktwits"><figcaption>STLA's Sentiment Meter and Message Volume as of 12:43 p.m. ET on Nov. 4, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user sounded skeptical about the stock’s poor performance this year.<stembedurl>https://stocktwits.com/TrainingBaker/message/634814607</stembedurl>STLA stock is down 24% this year and by about 27% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-draft-kings-stock-down-today/cL28KUeR36m">Why Is DraftKings Stock Down Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Jeep logo is displayed on a vehicle for sale at a dealership on April 12, 2025 in San Diego, California. (Photo by Kevin Carter/Getty Images)

Stellantis NV Recalls Over 320,000 Jeep Plug-In Hybrids In US Over Fire Risk

The recall includes certain model year 2020- 2025 Jeep Wrangler 4Xe and model year 2022-2026 Grand Cherokee 4Xe plug-in hybrid vehicles. 

<ul class="summary-bullets"><li>According to a CNBC report, the price of the product, known as Quark AI Glasses, during pre-sale would be at 4,699 yuan.</li><li>The report added that Alibaba will begin shipping the product&nbsp;in December.</li><li>The eyewear would help with a variety of tasks, including hands-free calling, music streaming, and real-time language translation, the report said.</li></ul>Alibaba (BABA) has reportedly announced the price of its soon-to-launch artificial intelligence glasses, which would go on pre-sale on October 24 on its e-commerce platform Tmall.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/10/23/alibaba-prices-ai-glasses-at-660-and-launches-chatgpt-rival.html">CNBC report</a> on Thursday, the price of the product, known as Quark AI Glasses, during pre-sale would be at 4,699 Chinese yuan ($659.4), and after applying several discounts, it would cost 3,999 yuan.The report added that Alibaba will begin shipping the product&nbsp;in December. U.S.-listed shares of Alibaba rose nearly 2% in premarket trading on Thursday.<h2 class="st-heading-2">Quark AI Glasses</h2>The CNBC report noted that Alibaba had first unveiled the Quark AI Glasses launch in July. It was one of the first products of its kind from Alibaba, and the glasses use the company’s Qwen large language model and its Quark AI assistant, it said.The report added that the eyewear would help with a variety of tasks, including hands-free calling, music streaming, and real-time language translation.CNBC reported that the Quark AI glasses are competing with Meta Platforms (META) smart glasses, which are made in collaboration with Ray-Ban.&nbsp;With the launch of Quark AI glasses, Alibaba will compete with another China-based consumer electronics player, Xiaomi, which unveiled its AI glasses this year, the report said.<h2 class="st-heading-2">AI Chat Assistant In Quark App</h2>Alibaba said it has launched advanced AI chat features in its Quark app as part of its plans to reach more individual users.&nbsp;Quark's chat feature enables users to communicate via text or voice, leveraging Alibaba’s advanced Qwen3 models. According to the company, the feature delivers improved reasoning, understanding, and task-handling performance.Retail sentiment on Alibaba remained unchanged in the ‘bearish territory, with message volumes at ‘low’ levels, according to data from Stocktwits.<a href="https://stocktwits.com/symbol/BABA">U.S.-listed shares of Alibaba</a> have gained over 95% this year.1 Chinese Yuan = $0.14For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/alibaba-puts-ai-chat-in-quark-app-eyes-consumers-in-latest-growth-push/cLG4ayxR3AL">Alibaba Puts AI Chat In Quark App, Eyes Consumers In Latest Growth Push</a>

2025/07/18: The "Alibaba" logo on a blue background at the 3rd China International Supply Chain Expo. 

Alibaba’s AI Glasses To Be Priced At $659, Pre-Sale Planned On October 24 Via Its E-commerce Platform Tmall: Report

According to a CNBC report, the price of the product, known as Quark AI Glasses, during pre-sale would be 4,699 yuan.

AstraZeneca (AZN) on Wednesday announced the unveiling of its expanded manufacturing facility in Texas aimed at doubling the production of its drug Lokelma.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251014866366/en/AstraZeneca-unveils-expanded-manufacturing-facility-in-Texas">invested</a> $445 million to expand the facility, it said. The unveiling <a href="https://stocktwits.com/news-articles/markets/equity/astrazeneca-announces-4.5-billion-dollar-investment-in-virginia/ch67yQKR31I">follows</a> the groundbreaking last week at the drugmaker’s $4.5 billion manufacturing facility in Albemarle County, Virginia. &nbsp;The investments are part of the company’s commitment to invest $50 billion in the U.S. by 2030, with the goal of reaching $80 billion in total revenue by then.The facility in Coppell, which employs more than 250 people, is the sole global manufacturing facility for AstraZeneca’s Lokelma, a prescription medicine for the treatment of high levels of potassium in the blood in adults, a condition known as hyperkalemia.The facility supplies the drug to more than 50 countries worldwide. <a href="https://stocktwits.com/symbol/AZN">AstraZeneca</a> said that through the expansion and development of a new 9,000 square foot building, two novel manufacturing lines will be added, along with enhancements to support drug substance and drug product laboratory testing, warehousing, additional manufacturing utilities, and administrative space.The increased investment in the U.S. by drugmakers follows President Donald Trump’s push to move pharmaceutical manufacturing to American soil. Last month, President Trump announced on Truth Social that the United States will impose a 100% tariff on branded and patented pharmaceutical products effective October 1, unless manufacturers actively build plants in the country. Trump is also pressuring drugmakers to lower drug prices in the U.S. to levels comparable to those paid by other wealthy nations.On Stocktwits, retail sentiment around AZN stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.AZN stock is up by 29% this year and by about 8% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-says-oral-glp-1-drug-reduced-blood-sugar-levels-in-two-late-stage-trials/ch6nxr4R3Nm">Eli Lilly Says Oral GLP-1 Drug Reduced Blood Sugar Levels In Two Late-Stage Trials</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The international biopharmaceutical company AstraZeneca office building in Shanghai, China on June 27, 2025. 

AstraZeneca Unveils Expanded Facility In Texas Aimed At Doubling Production Of Hyperkalemia Drug

The facility in Coppell, which employs more than 250 people, is the sole global manufacturing facility for the company’s Lokelma. 

Drugmaker AstraZeneca (AZN) on Thursday said that it will invest $4.5 billion in a new manufacturing facility in Virginia amid President Donald Trump’s push to move pharmaceutical manufacturing to American soil.The investment is $500 million more than initially planned and is intended to support the enhanced manufacturing capability of a broader range of medicines, including weight management, metabolic, and cancer technologies, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251009456597/en/AstraZeneca-plans-to-increase-investment-and-scope-of-its-Virginia-manufacturing-facility-to-%244.5-billion-creating-3600-new-jobs">said.</a>The new facility will be located at Rivanna Futures in Albemarle County, and the company expects the facility to create 600 skilled jobs and an additional 3000 jobs to support the facility’s construction. The construction will start immediately, and the facility is expected to be operational in the next four to five years, the company added.The new announcement is part of the company’s commitment to invest $50 billion in the U.S. by 2030, with the goal of reaching $80 billion in total revenue by then. AstraZeneca CEO Pascal Soriot on Thursday noted that the investment in Virginia is the largest in the company’s history.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AZN">AZN stock</a> stayed within the ‘neutral’ territory over the past 24 hours, while message volume dropped from ‘normal’ to ‘low’ levels.<figure class="image"><img style="aspect-ratio:996/126;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_09_at_1_46_59_PM_png_5e85c683cb.webp" alt="AZN's Sentiment Meter and Message Volume as of 1:47 p.m. ET on Oct. 09, 2025 | Source: Stocktwits" width="996" height="126"><figcaption>AZN's Sentiment Meter and Message Volume as of 1:47 p.m. ET on Oct. 09, 2025 | Source: Stocktwits</figcaption></figure>Last month, President Trump announced on Truth Social that the United States will impose a 100% tariff on branded and patented pharmaceutical products starting October 1, unless manufacturers actively build plants in the country. Trump is also pressuring drugmakers to lower drug prices in the U.S. to levels comparable to those paid by other wealthy nations.Last month, AstraZeneca <a href="https://stocktwits.com/news-articles/markets/equity/astrazeneca-plans-ordinary-share-listing-in-us/chDub9CR376">announced</a> that it plans to list its ordinary shares on the New York Stock Exchange, replacing its existing U.S. listing of American Depositary Receipts (ADRs) on Nasdaq. The move is part of the company’s efforts to expand its access to capital, it had said, while noting that the U.S. has the world’s largest and most liquid public markets by capitalization.AZN stock is up by 31% this year and by 10% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-reportedly-intends-to-launch-longer-range-model-y-variant-in-china/ch67xJOR315">Tesla Reportedly Intends To Launch A Longer Range Model Y Variant In China</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

AstraZeneca Announces $4.5B Investment In Virginia 

The investment is $500 million more than initially planned, intended to support the enhanced manufacturing capability of a broader range of medicines, according to the company. 

AstraZeneca (AZN) plans to list its ordinary shares on the New York Stock Exchange, replacing its existing U.S. listing of American Depositary Receipts (ADRs) on Nasdaq, the pharmaceutical giant announced on Monday.The move is part of the company’s efforts to expand its access to capital, including in the U.S. Nasdaq-listed ADRs of the company traded 1% higher in the pre-market session at the time of writing.Following the implementation of the new and harmonized listing structure, shareholders will be able to trade their interests in AstraZeneca ordinary shares across the London Stock Exchange (LSE), Nasdaq Stockholm (STO), and the New York Stock Exchange (NYSE), the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.astrazeneca.com/media-centre/press-releases/2025/astrazeneca-to-harmonise-its-listing-structure-across-the-london-stock-exchange-nasdaq-stockholm-and-new-york-stock-exchange.html">said</a>.Michel Demaré, Chair of AstraZeneca, stated that enabling a global listing structure would allow the company to reach a broader mix of global investors and make it even more attractive to all its shareholders, while remaining headquartered in the U.K. The plan will now be put to a vote on November 3.On Stocktwits, retail sentiment surrounding <a href="https://stocktwits.com/symbol/AZN">AZN stock</a> remained within the ‘bearish’ territory while message volume stayed at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:578/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_29_at_6_49_19_AM_png_073b67d335.webp" alt="AZN's Sentiment Meter and Message Volume as of 6:49 a.m. ET on Sept. 29, 2025 | Source: Stocktwits" width="578" height="62"><figcaption>AZN's Sentiment Meter and Message Volume as of 6:49 a.m. ET on Sept. 29, 2025 | Source: Stocktwits</figcaption></figure>AstraZeneca stated that the U.S. has the world’s largest and most liquid public markets by capitalization. The new listing structure will not alter the company’s status as a U.K.-listed, headquartered, and tax-resident company, the company added.In 2024, the United States accounted for 43% of AstarZeneca’s total revenue. The U.S. accounted for $23.23 billion in revenue while Europe accounted for 23% of total revenue, or $12.19 billion.In July, the company also announced a $50 billion investment in the U.S. by 2030, which would include the expansion of its research and development facility in Maryland, as well as manufacturing facilities for cell therapy in Rockville, Maryland, and Tarzana, California, among others.It had then stated that the investments would help it achieve its goal of reaching $80 billion in total revenue by 2030, with half of that revenue to be generated in the U.S. AZN shares are up by 13% this year but down by over 5% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-regulator-closes-probe-into-stellantis-24000-alfa-romeo-vehicles/chDM6PoR37x">US Regulator Closes Probe Into Stellantis’ 24,000 Alfa Romeo Giulia Vehicles</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure

Michel Demaré, Chair of AstraZeneca, stated that enabling a global listing structure would allow the company to reach a broader mix of global investors and make it even more attractive to all its shareholders. 

The National Highway Traffic Safety Administration (NHTSA) announced on Monday that it has closed its investigation into approximately 24,000 model year 2017-2018 Alfa Romeo Giulia vehicles.The U.S. auto safety regulator’s Office of Defects Investigation (ODI) had opened the probe in January 2024 to assess allegations of loss of motive power resulting from low-pressure fuel pump failures in certain Alfa Romeo Giulia vehicles. During its investigation, the NHTSA <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://static.nhtsa.gov/odi/inv/2024/INCLA-PE24003-86036.pdf">determined</a> that the vehicles were equipped with fuel delivery pumps supplied by Vitesco Technologies Germany GmbH.However, Stellantis issued a recall earlier this month covering 29,467 model-year 2017–2019 Alfa Romeo Giulia vehicles and 24,382 model-year 2018 Alfa Romeo Stelvio vehicles, all equipped with the suspect Vitesco fuel delivery pump. A remedy is under development, the company said.The NHTSA stated that it is closing its probe in light of the recall issued by Stellantis. However, the regulator said it reserves the right to take additional action if warranted.The NHTSA also noted that it is aware of 1,900 vehicles experiencing failures related to the issue, adding that it is aware of one crash associated with the issue, but no injuries, fatalities, or fires.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/STLA">STLA stock</a> remained within ‘bearish’ territory while message volume remained at ‘high’ levels.The NHTSA also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://static.nhtsa.gov/odi/inv/2024/INCLA-PE24006-86034.pdf">announced </a>on Monday that it has closed a probe into 226,250 model year 2018-2020 Dodge Journey vehicles, which was initiated in February 2024 due to complaints regarding the backup camera function. The company recently issued a recall to resolve the issue and noted that it will replace defective cameras in the recalled vehicles with an updated part that resolves the problem.STLA stock is down 29% this year and approximately 34% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pharma-lobby-announces-new-website-to-connect-patients-with-manufacturer-direct-patient-programs/chDuciYR3JJ">Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Programs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A new Alfa Romeo Giulia on display at the Edmonton Motor Show on April 13, 2025, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)

US Regulator Closes Probe Into Stellantis’ 24,000 Alfa Romeo Giulia Vehicles

The U.S. auto safety regulator’s Office of Defects Investigation (ODI) had opened the probe in January 2024 to assess allegations of loss of motive power resulting from low-pressure fuel pump failures. 

The U.S. Food and Drug Administration has sent a letter to Novo Nordisk (NVO) CEO Maziar Mike Doustdar regarding the company’s promotional communication featuring Oprah Winfrey, alleging that the video is false or misleading.The video originally appeared on ABC as a Primetime Oprah Special on March 18, 2024. It also subsequently appeared on Hulu. The video is a 42-minute special program hosted by Oprah Winfrey, featuring patient testimonials from individuals who struggle with obesity and excessive weight, including those who have used Novo’s Wegovy, Ozempic, or Victoza.The FDA <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025">alleged</a> in a letter dated September 9 that the video misbranded Novo’s Wegovy, Ozempic, and Victoza, making its distribution violative. The video was also not submitted at the time of initial dissemination or publication as required by law, the agency said.“These violations are concerning from a public health perspective because the promotional communication creates a misleading impression regarding the safety of Wegovy, Ozempic, and Victoza, which are drugs with multiple serious, potentially life-threatening risks,” the agency said.The FDA also noted that obesity and type 2 diabetes are significant public health concerns in the U.S., and consumers who seek medical treatment for these conditions should receive truthful and nonmisleading information regarding the serious risks associated with the use of the drugs. While Novo’s Wegovy is used for weight management, its Ozempic and Victoza are used to treat type 2 diabetes.The FDA said that several advisory comments dated as long back as 2010 addressed draft promotional communications for Victoza with certain similarities to the aforementioned video. The agency expressed concerns that <a href="https://stocktwits.com/symbol/NVO">Novo</a> is promoting the three drugs in a manner that fails to present the serious risks of these drug products in a truthful and nonmisleading manner, despite the FDA’s prior comments.While the video includes numerous representations of the benefits of Wegovy, Ozempic, and Victoza made by representatives of Novo Nordisk, it omits important risk information or minimizes the risks associated with these drug products, the FDA said. Only four minutes in total were devoted to the important risks associated with GLP-1 drugs, such as Wegovy, the FDA said.The video also omits reference to how the drugs are contraindicated in patients with a personal or family history of Medullary Thyroid Cancer or in patients with Multiple Endocrine Neoplasia syndrome type 2, it added. The omissions are exacerbated by statements from Amanda Velazquez, a paid consultant of Novo, made on the video, the FDA said.NVO stock is down by 33% this year and by 58% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/hims-and-hers-stock-tumbles-7-percent-after-fda-letter/chwyNFWRdzV">Hims &amp; Hers Stock Draws Investor Attention After Tumbling 7% – Here’s What Happened</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Ozempic manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on December 7, 2023. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

US FDA Alleges Novo Nordisk’s Video On Weight-loss Drugs Featuring Oprah Winfrey Is ‘False Or Misleading’ 

The FDA alleged in a letter dated September 9 that the video misbranded Novo’s Wegovy, Ozempic, and Victoza, making its distribution violative. 

DFAX
Dimensional ETF Trust - Dimensional World ex U.S. Core Equity 2 ETF

Feed

News

Sentiment

Fundamentals

Info

Latest DFAX News

DFAXDimensional ETF Trust - Dimensional World ex U.S. Core Equity 2 ETF